4:26 PM ET
8-K
Business Update
Crescent Biopharma Business Update
Crescent Biopharma provided a comprehensive clinical pipeline update, including the commencement of chemotherapy combination cohorts in its Phase 1/2 ASCEND trial for CR-001. The company also announced the initiation of combination studies with Kelun-Biotech and set expectations for initial monotherapy data readouts in Q1 2027.
- Counterparty
- Kelun-Biotech Biopharmaceutical Co., Ltd.